Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR

Overview of attention for article published in Molecular Cancer Therapeutics, May 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 3,862)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 54 news outlets
blogs: 1 blog
twitter: 7 tweeters

patent: 1 patent
facebook: 1 Facebook page

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 82 Mendeley

Summary News Blogs Twitter Patents Facebook Dimensions citations

So far, Dimensions has found 34 publications that cite this research output.

34

The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.

Prognostic significance of the urokinase plasminogen activator system in tissue and serum of dogs with appendicular osteosarcoma

Article in PLOS ONE (September 2022)

Emerging trends in immunotoxin targeting cancer stem cells

Article in Toxicology in Vitro (June 2022)

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer

Article in Journal of Translational Medicine (March 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.